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The principal function of intermediate ®laments is to strengthen cells. Their developmentally regulated, tissue-speci®c
patterns of expression further suggest that they modulate cellular structural properties during development. To explore
the role of intermediate ®laments in development, we injected RNA encoding a truncated form of the Xenopus laevis
middle-molecular-weight neuro®lament protein (NF-M) into embryonic frog blastomeres at the 2-cell stage. A similar
truncated form of mammalian NF-M disrupts neuro®laments (Type IV) and vimentin (Type III) intermediate ®laments in
transfected ®broblasts. In cultures made from dissociated neural tubes and their adjacent myotomes, the resultant protein
disrupted both desmin ®laments in muscle cells and neuro®laments in neurons during the ®rst day of culture, which
corresponds to stage 35/36 in the intact embryo. We next examined the effects of this truncated neuro®lament protein on
development of the nervous system. The greatest effects were seen on development of cranial and primary motor nerves,
which were severely stunted as late as stage 37/38. In addition to these effects, ectopic neurons also appeared immediately
beneath the epidermis along the ¯ank of tadpoles expressing the truncated neuro®lament protein. Whereas the former
effects on peripheral nerve development were nearly identical to effects obtained with injected neuro®lament antibodies,
the ectopic neurons were novel, suggesting they resulted from the disruption of intermediate ®laments other than the
neuro®laments. These experiments thus implicate intermediate ®laments in several functions important for normal neural
development. q 1996 Academic Press, Inc.
INTRODUCTION neuro®lament protein (NF-H) emerges, and both NF-H and
NF-M become progressively more phosphorylated in axons
(Carden et al., 1987). These progressive modi®cations haveThe developmentally regulated, tissue-speci®c expres-
given rise to the hypothesis that alterations in neuro®la-sion of intermediate ®lament proteins has long suggested
ment subunit composition help axons to accommodate thethat they play important roles during embryonic develop-
changing structural demands of growth and maturationment (Tapscott et al., 1981). Because intermediate ®lament
(Fliegner et al., 1994).proteins form one of the most stable polymers of the cy-
The principal evidence for the idea that intermediate ®l-toskeleton, it is assumed that their role is chie¯y structural.
aments strengthen cells has come from a variety of geneticHowever, their large number and complex patterns of ex-
studies that have emphasized the importance of intermedi-pression during embryogenesis further suggest that they are
ate ®laments in establishing normal mature phenotypes.somehow integral to cellular differentiation and morpho-
For example, mutations in speci®c human cytokeratins re-genesis. For example, during development of the mamma-
sult in fragile keratinocytes. These become prone to rupturelian central nervous system, undifferentiated neural tube
upon mild physical trauma (Fuchs, 1994; Fuchs and Weber,cells express nestin (Hock®eld and McKay, 1985; Lendahl
1994). In the nervous system, a nonsense mutation in NF-et al., 1990) and vimentin (Bignami et al., 1982; Houle and
L found in the quiver mutant strain of the Japanese quailFedoroff, 1983). In newly differentiated neurons, these two
results in axons depleted of neuro®laments. Although theseproteins are replaced by a-internexin. Later, the middle (NF-
birds are viable, they exhibit continuous mild tremors, andM)- and low (NF-L)-molecular-weight neuro®lament triplet
their peripheral nerves contain fewer and signi®cantlyproteins are added, and their expression increases as a-in-
smaller myelinated axons (Yamasaki et al., 1991; Zhao etternexin expression declines (Kaplan et al., 1990; Fliegner
et al., 1994). As axons mature, the high-molecular-weight al., 1995).
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Proof of a role for intermediate ®laments in development
has been slow to appear. Indeed, transgenic mice that lack
endogenous vimentin, which is one of the most abundant
intermediate ®lament proteins of normal embryos, have no
overt phenotype (Colucci-Guyon et al., 1994). Similarly,
disruption of vimentin ®laments by expression of truncated
vimentin has no effect on early development in Xenopus
laevis embryos (Christian et al., 1990). However, deleteri-
ous effects are caused by disruption of other types of inter-
mediate ®laments in Xenopus embryos. For example, elimi-
nation of maternally expressed cytokeratins increases the
incidence of abnormal gastrulation and hinders wound heal-
ing (Torpey et al., 1992; Klymkowsky et al., 1992). Disrup-
tion of intermediate ®laments in developing dorsal myo-
tomes by expression of truncated desmin and vimentin dis-
organizes both the sarcolemmal membrane and the
attachments of myo®brils to the membrane at the interso-
mite junction (Cary and Klymkowsky, 1995). In the nervous
system, injection of antibodies to NF-M into embryonic
FIG. 1. Schematic drawings illustrating the cDNA used for inblastomeres subsequently interferes with proper peripheral
vitro transcription of Xenopus laevis truncated NF-M (NF-MDT).nerve development of intact embryos (Szaro et al., 1991),
The coding domain of full-length NF-M (middle drawing), con-and in dissociated neural tube cultures, it reduces axonal
sisting of 897 amino acids, can be subdivided into an N-terminalelongation and produces abnormal axonal morphologies
head domain, a central rod domain, and a C-terminal tail domain(Lin and Szaro, 1995).
(open bars, middle drawing). NF-MDT (bottom drawing), whichThis investigation extends the previous experiments that contains the N-terminal head domain and a truncated rod domain,
used antibodies to disrupt neuro®laments during Xenopus was prepared from full-length NF-M by PCR. The PCR introduced
development. In the present study, we have injected RNA a stop codon at amino acid 392 (indicated by the downward arrow
that encodes a truncated form of Xenopus NF-M into em- following the sequence KLLEG). The PCR product was also ¯anked
bryonic blastomeres at the 2-cell stage. An analogous trun- by HindIII/NotI sites at the 5* end and NotI/BamHI sites at the 3*
end, which were built into the primers. NF-MDT cDNA was in-cated mammalian NF-M disrupts both cotransfected neuro-
serted between the HindIII and BamHI sites of pGem3z, down-®laments and endogenous vimentin of cultured ®broblasts
stream of the SP6 promoter (indicated by the large arrow under-(Wong and Cleveland, 1990; Chin et al., 1991). This injected
neath the bar ®lled with horizontal stripes in the top drawing). ARNA produced a truncated NF-M protein, which persisted
fragment of cDNA encoding the 3* untranslated domain of rabbitthrough the ®rst day of axonal development (stage 35/36)
b-globin (bar ®lled with vertical stripes) was inserted at the 3* end ofand disrupted neuro®laments. In addition, it also had a more
NF-MDT to increase the stability of the mRNA. The approximate
generalized effect on intermediate ®laments, as demon- location of an XhoI site, which was used to linearize the templates
strated by the disruption of desmin ®laments in muscle prior to transcription and which is downstream from a polyadenyla-
cells. tion signal, is also indicated.
These experiments thus provided an opportunity not only
to con®rm the previous interference with normal axonal
development caused by injected neuro®lament antibodies,
molecular-weight neuro®lament protein (NF-M). This constructbut also to explore more generalized consequences of inter-
was designed to express a protein analogous to a mammalian trun-mediate ®lament disruption on neural development. In con-
cated NF-M that has been shown previously to disrupt assembly
®rmation of our antibody studies, we found that expression of both type III (vimentin) and type IV (neuro®lament protein) inter-
of truncated NF-M stunted normal development of cranial mediate ®laments in transfected mouse ®broblasts (Wong and
and primary motor nerves. In addition, we also found ec- Cleveland, 1990). A full-length cDNA of a form of X. laevis NF-
topic neurons along the ¯anks of tadpoles, a different effect M (Sharpe, 1988) was assembled from clones isolated in our own
laboratory and inserted into the EcoRI site of pSPORT1 (Life Tech-than was observed with antibody injections. The latter re-
nologies, Gaithersburg, MD). After linearization with KpnI, thissult suggests that intermediate ®laments are important for
plasmid (pSPORT1/NF-M) was used as the template in the poly-additional aspects of neural development than formerly rec-
merase chain reaction (PCR) to generate a truncated NF-M. Theognized.
PCR was primed with oligonucleotide primers in sense (5*-ATA-
AAGCTTGCGGCCGCGTCTTCCAGGATGAGTTACT-3*) and
antisense (5*-ATAGGACCGCGGCCGCTTAACCCTCCAAAA-MATERIALS AND METHODS
GTTTCCTGTATGC-3*) orientations. To facilitate cloning, these
primers introduced HindIII/NotI and NotI/BamH1 restriction sitesPreparation of mRNA by in Vitro Transcription
at the 5* and 3* ends, respectively, of the PCR product. The anti-
sense primer also introduced a stop codon at amino acid positionWe constructed the plasmid pSP6NF-MDT (Fig. 1) to be used as
template for in vitro transcription of a X. laevis truncated middle- 392, which is near the end of the rod domain of NF-M (following
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the sequence KLLEG) and results in the deletion of the entire C- NF-MDT or b-galactosidase, respectively. In contrast, at 4±6 ng of
RNA, only 69% of the embryos injected with NF-MDT were nor-terminal tail domain as well as six amino acids from the carboxyl
terminus of the rod (Fig.1). This DNA was then inserted between mal, compared to 85% of the b-galactosidase controls. Nearly all
of the embryos that died as a result of NF-MDT injection did sothe HindIII and BamH1 sites of pGEM3z (Promega, Madison, WI),
downstream of the SP6 promoter. In addition, a segment of the 3* before or during gastrulation. As a result of these trials, we decided
to use 1±2 ng of RNA and to concentrate on those tadpoles thatuntranslated region of rabbit b-globin, obtained by isolating a 2.3-
kb BamHI fragment of pSP6uncbgal (R. Harland, U.C. Berkeley), appeared grossly normal for the rest of our investigations.
was inserted after the 3* end of the truncated NF-M cDNA insert.
This segment contains a polyadenylation signal upstream of an
Preparation of Dissociated Neural Tube Culturesinternal XhoI site, and addition of this fragment increases the sta-
bility of injected RNAs through neurula stages (Vize et al., 1991).
After injection, embryos were raised to stage 22, which is justA plasmid carrying a cDNA insert encoding b-galactosidase
before endogenous NF-M expression begins in the developing spinal(pSP6uncbgal; R. Harland, U.C. Berkeley) was used to make another
cord (Szaro et al., 1989). At this stage, healthy embryos were placedmRNA. RNA transcribed from this plasmid, which carries a nu-
into sterile-®ltered Hepes-buffered Steinberg's solution [HBS; 58.2clear localization signal, has been used as a control in many Xeno-
mM NaCl, 0.67 mM KCl, 0.34 mM Ca(NO3)2, 0.83 mM MgSO4 , 5pus studies (Vize et al., 1991; Smith and Harland, 1991). In our
mM Hepes, pH 7.6]. The vitelline membrane was removed manu-study, we used this RNA to enable us to determine whether the
ally and the developing spinal cord together with adjacent epithelia,injections were successful and to monitor the toxicity of the
somites, and notochord were dissected free. These were incubatedamount of RNA injected into the embryos.
in a solution of collagenase (0.5 mg/ml, type IV, Sigma, St. Louis,pSP6NF-MDT and pSP6uncbgal were linearized with XhoI and
MO) for 30 to 50 min and then transferred to HBS. The neural tubeused as templates for in vitro transcription of 5* terminal-capped
and adjacent myotomes were isolated and incubated in calcium±RNA by SP6 RNA polymerase using a Message Machine kit (Am-
magnesium-free HBS containing 0.5 mM EDTA for an additionalbion, Austin, TX). The resultant RNA was dissolved in milli-Q
30 to 60 min. Tissues from a single embryo were dissociated bywater, and its concentration determined spectrophotometrically
gentle trituration through a micropipette, and these cells were(Davis et al., 1994).
placed into 35-mm culture dishes containing medium [60% Lei-
bowitz L-15 with glutamine (Life Technologies, Gaithersburg, MD),
39% HBS, 1% CPSR-1 serum substitute (Sigma)]. Culture dishesMicroinjection Procedures were made of D polystyrene plastic (Nunclon, Naperville, IL),
which provides a uniform substrate that minimizes variations inMicroinjection procedures were similar to those described pre-
rates of neuritic outgrowth between dishes (Lin and Szaro, 1994).viously for antibody injection (Lin and Szaro, 1995), except that
We have shown previously that in these cultures the neuro®lamentglass capillaries without ®laments (WPI TW150-4; World Precision
proteins XNIF, NF-M, NF-L, and phosphorylated epitopes of NF-Instruments, Sarasota, FL) and smaller pipette tips were used (tip
M emerge with the same time course as in the intact embryo (Lindiameter, 3±5 mm). Such modi®cations were necessary because
and Szaro, 1994).of the reduced viscosity of RNA solutions over protein solutions.
Injections were delivered via an electronically gated apparatus (Pi-
cospritzer II, Fair®eld, NJ), which was pneumatically driven by
X-gal Staining for b-Galactosidasepressure from a tank of dry nitrogen.
Before injection, RNA solutions were centrifuged brie¯y to pellet Whole tadpoles or neural tube cultures derived from embryos
any insoluble material. Single blastomeres at the 2-cell stage were injected with b-galactosidase mRNA were ®xed in a solution con-
injected with 4 to 8 nl of RNA solution. The experimental group taining 1% paraformaldehyde, 0.2% glutaraldehyde, and 0.02% Tri-
received a mixture of NF-MDT RNA (0.3 ng/nl) and b-galactosidase ton in phosphate-buffered saline (PBS) at pH 6.8 for 15 ±30 min.
RNA (0.1 ng/nl). The control group was injected with b-galactosi- They were then rinsed several times with PBS and incubated in an
dase RNA (0.4 ng/nl). Only embryos that had cleaved symmetri- X-gal developing solution, which contained 2 mM MgCl2, 5 mM
cally were selected for injections, which were targeted to a site potassium ferrocyanide, 5 mM potassium ferricyanide, and 0.05%
near the animal pole. Injection parameters were adjusted (volume X-gal (US Biochemicals, Cleveland, OH) in PBS (pH 6.8). After 10±
and target site) so that embryos would be routinely labeled through- 30 min, the reaction was terminated by several washes of PBS.
out the neural tube and dorsal myotomes on one side of the midline,
since injected RNAs diffuse slowly away from the injection site
(Vize et al., 1991). Antibodies Used for Western Blots and
Some of the embryos used for tissue culture (see Results) received Immunocytochemical Studies
bilateral injections, one in each blastomere. Otherwise, only one
blastomere was injected. The latter resulted in mRNA expression Two separate monoclonal antibodies to nonphosphorylated epi-
topes of X. laevis NF-M were used, XC10C6 (Szaro and Gainer,con®ned to one side of the midline of the animal, and thus the
uninjected contralateral side acted as an internal control. 1988) and RMO270 (Wetzel et al., 1989). The RMO270 epitope is
in the C-terminal tail domain of NF-M, and thus this antibodyIn a preliminary set of experiments to determine appropriate dos-
ages for RNA injections, 172 embryos from three spawnings were recognizes endogenously expressed NF-M but not the NF-MDT
protein. The XC10C6 antibody binds to an epitope within eitherinjected with 1±2 ng of NF-MDT RNA, and 148 embryos were
injected with 4±6 ng of the same RNA. From these same spawn- the head or rod domain of NF-M, and it therefore recognizes both
the NF-MDT protein and endogenous NF-M. A rabbit antiserumings, 134 embryos received control injections of 1±2 ng of b-galac-
tosidase RNA, and 73 received 4±6 ng. An additional 140 embryos (LC2) against the low-molecular-weight Xenopus neuronal inter-
mediate ®lament protein (XNIF) (Charnas et al., 1992) was alsofrom these same three spawnings acted as uninjected controls. At
stage 22, 94% of the uninjected embryos had developed normally, used along with RMO270 to monitor effects on endogenous neuro-
®laments. A monoclonal antibody (8D12) against MAP-1 was usedcompared to 83 and 89% of the embryos injected with 1±2 ng of
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to label axons independently of neuro®laments, since in previous
experiments we have shown that the distribution of microtubules
is unaffected by disruption of the neuro®laments (Lin and Szaro,
1995). This antibody recognizes a single band (250 kDa) on West-
ern blots of X. laevis spinal cord or brain. A commercially available
monoclonal antibody (DE-B-5; Oncogene Science, Cambridge, MA)
was used to monitor effects on desmin (Cary and Klymkowsky,
1994). The following dilutions were used both on Western blots and
in immunocytochemical procedures: anti-XNIF antiserum, 1:500;
RMO270 hybridoma supernatant, 1:100; XC10C6 ascites ¯uid,
1:1,000; anti-MAP1 hybridoma supernatant and anti-desmin anti-
body, 1:200.
Western Blot Analysis of NF-MDT
Protein Expression
FIG. 2. Western blot analysis of expression of NF-MDT protein.
Western blots were performed as described more extensively in Whole embryo homogenates were resolved on 7.5% SDS±PAGE,
Zhao and Szaro (1994). Homogenates of whole embryos were pre- blotted onto nitrocellulose membrane, and detected by a mono-
pared from 10 embryos in 200 ml of SDS/urea sample buffer. Pro- clonal antibody against the head/rod domain of X. laevis NF-M
teins were separated by SDS gel electrophoresis on 7.5% polyacryl- (XC10C6, 1:1000). This antibody recognizes both NF-MDT protein
amide gels and electroblotted onto nitrocellulose membrane. Pri- and endogenous NF-M. Lanes 1 and 2 were from embryos injected
mary antibody bound to antigen was visualized with a peroxidase- with NF-MDT mRNA and sacri®ced at stages 22 (lane 1) and 35/
conjugated secondary antibody which was developed in a solution 36 (lane 2); lanes 3 and 4 were from uninjected controls at the same
containing glucose oxidase and diaminobenzidine. stages. Two bands at approximately 50 and 48 kDa were detected
by XC10C6 in the injected embryos at stage 22 (lane 1; arrowhead),
whereas these were absent from the uninjected controls at the same
Immunocytochemical Procedures stage (lane 3). At stage 35/36, NF-MDT protein was barely detect-
able (lower arrowhead, lane 2), and endogenous NF-M was easilyTadpoles through stage 37/38 were immunostained as whole-
visible (lanes 2 and 4; upper arrowhead).mounts according to procedures described more extensively else-
where (Dent et al., 1989; Szaro et al., 1991). Brie¯y, embryos were
®rst ®xed in 0207C methanol and then post®xed in Dent's ®xative
(four parts methanol:one part DMSO) on ice. The embryos were
injected at the 2-cell stage could persist in developing mus-then treated in acetone for 7 min at 0207C. After several washes in
cle cells and neurons during the initial phases of neuralTris-buffered saline with 1% DMSO, the embryos were incubated
development and axon outgrowth, we assayed with X-galovernight in primary antibody containing DMSO, followed by a
for the expression of b-galactosidase in dissociated neuralsecond incubation in horseradish peroxidase-conjugated secondary
tube cultures made from embryos unilaterally injected withantibody. The embryos were then developed in a solution con-
taining diaminobenzidine as the chromogen. After dehydration in mRNA transcribed from pSP6uncbgal. Thus, these cultures
methanol, embryos were cleared and stored in benzyl alcohol:ben- were a mix of cells derived from the injected and uninjected
zyl benzoate (1:2). blastomeres. Cultures were prepared from stage 22 embryos
The detailed procedures for immuno¯uorescence staining of cul- and stained for b-galactosidase at the end of 1 day in culture,
tures have been described previously as well (Lin and Szaro, 1994; which coincides with stage 35/36 in the embryo (Lin and
Lin and Szaro, 1995). Cultures were ®xed in methanol and incu-
Szaro, 1994). During development, process outgrowth of spi-bated with primary antibody overnight. The biotinylated secondary
nal neurons begins as early as stage 20, and the ®rst primaryantibody was diluted 1:800; and rhodamine and ¯uorescein avidin
motor axons to reach their targets do so by stage 26 (Jacob-D (Vector Laboratories, Burlingame, CA) were diluted 1:1000.
son and Huang, 1985). This period of culture therefore spans
the ®rst day of axonal development. Cells that expressed b-
galactosidase had nuclei that stained blue, due to the nu-RESULTS
clear localization signal of pSP6uncbgal, and both neurons
and muscle cells expressing b-galactosidase had normalExpression of NF-MDT and Disruption
morphologies.of Intermediate Filaments in Cultured
Expression of NF-MDT in embryos and tissue culture.Neurons and Muscle Cells
To con®rm expression of NF-MDT protein after injection
of its RNA, we analyzed homogenates of whole embryosIn the ®rst section under Results, we established that
expression of NF-MDT disrupted the normal intermediate on Western blots at various stages (stages 8, 22, and 35/36).
At stage 8, neither NF-MDT nor b-galactosidase expression®lament organization of both muscle cells and neurons dur-
ing the ®rst day of culture, which corresponds to stage 35/ could be observed (not shown), but by stage 22, expression of
exogenous proteins was readily detectable. Figure 2 shows36 in the larval tadpole.
Expression of control mRNA in muscle cells and neu- analysis by Western blot of the expression of NF-MDT as
detected by the XC10C6 antibody, which recognizes an epi-rons. To establish that proteins transcribed from mRNA
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FIG. 3. Expression of NF-MDT protein in muscle cells, which normally do not express endogenous NF-M. (A) A cultured muscle cell
derived from a blastomere injected with NF-MDT mRNA, as viewed with phase-contrast optics. (B) The same cell as in A, stained by the
anti-NF-M head/rod antibody (XC10C6) and viewed by ¯uorescence microscopy. Staining appears as discrete patches within the cytoplasm.
(C) A cultured muscle cell from an uninjected embryo. (D) The same cell as in C, indicating the absence of endogenous XC10C6 staining
in muscle cells. The scale bar applies to all of the panels.
tope within the head/rod of NF-M. Expression of endoge- XC10C6 staining in muscle cells descended from embryos
bilaterally injected at the 2-cell stage with NF-MDTnous NF-M, which begins at stage 24 (Szaro et al., 1989),
could be seen at stage 35/36 (lanes 2 and 4). Two additional mRNA. Normally, muscle cells of uninjected embryos are
devoid of anti-NF-M immunoreactivity, as shown in Fig.bands (50 and 48 kDa, arrowheads) were detected in em-
bryos injected with NF-MDT mRNA (lanes 1 and 2), but 3D. However, virtually all (98%) muscle cells derived
from NF-MDT mRNA-injected embryos were stained in-not in control embryos (lanes 3 and 4). The size of these
bands was consistent with the predicted molecular weight tensely by the XC10C6 antibody (Fig. 3B). Rather than ®ll-
ing the muscle cytoplasm, staining occurred in discreteof the NF-MDT protein. (X. laevis NF-M has two ATG-
methionine codons, 16 amino acids apart at the 5* end. patches (see below for a more extensive discussion). As ex-
pected, because muscle cells normally do not express NF-M,Either this or differential phosphorylation of serine residues
in the head domain of the molecule could account for the no such staining was obtained with the RMO270 antibody
directed against the tail domain of NF-M (not shown). Thus,presence of the two bands.) Moreover as expected, these
induced bands were undetectable with the RMO270 anti- in our present study, NF-MDT expression minimally
spanned stages 22 and 35/36, which is when initial axonalbody, whose epitope lies within the NF-M tail domain de-
leted from NF-MDT (not shown). Whereas expression of development happens.
Disruption of endogenous intermediate ®lament organi-NF-MDT protein was readily detectable at stage 22 (lane
1), it declined to a level of expression that was barely detect- zation in cultured neurons and muscle cells. Normally,
neuro®laments extend the full length of all neurites presentable at stage 35/36 (lane 2).
Whereas expression of NF-MDT was barely detectable on in 1-day-old tissue cultures (Lin and Szaro, 1994). To deter-
mine the effect of NF-MDT expression on neuro®lamentWestern blots at stage 35/36, it was nevertheless readily
detectable in cultured muscle cells at the equivalent age organization, we stained tissue cultures prepared from em-
bryos bilaterally injected at the 2-cell stage with antibodies(1 day). Figure 3 shows NF-MDT expression detected by
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directed at endogenous neuro®lament proteins (RMO270 embryos injected with b-galactosidase RNA (Figs. 5E and
5F) was identical to that of uninjected embryos (Figs. 5Aand anti-XNIF). Injections were made bilaterally to ensure
that all cultured neurons were descended from a blastomere and 5B).
injected with NF-MDT. We con®rmed the success of injec-
tions by staining the remainder of the embryo with X-gal
Effects of NF-MDT Expression on Nervousafter spinal cord segments were removed. Only tissue cul-
System Developmenttures derived from embryos whose head and remaining cau-
dal spinal cord were bilaterally stained blue by X-gal were The results presented so far demonstrated that expression
of NF-MDT disrupted the normal organization of interme-used for analysis. This was done rather than staining cul-
tures directly, since the ®xatives and reagents used for X- diate ®laments, affecting, for example, both the neuro®la-
ments of neurons and the desmin ®laments of muscle cells.gal staining destroyed the epitopes of our neuro®lament
antibodies. Since others have already examined the effects of desmin
disruption on the development of the dorsal myotome inFigure 4 shows examples of neurons stained by the
RMO270 antibody, which recognizes only endogenous NF- Xenopus (Cary and Klymkowsky, 1995), we concentrated
on the nervous system. In these experiments, embryos wereM. All neurons derived from embryos bilaterally injected
with only b-galactosidase RNA showed normal distribu- injected with NF-MDT RNA into a single blastomere at the
2-cell stage. They were then examined either at stage 28,tions of endogenous NF-M staining (Figs. 4A and 4B; more
than 100 neurons from three cultures). For embryos bilater- for early stages of axonal outgrowth, or at stage 37/38, to
allow time for the cranial ganglia to develop. Developingally injected with NF-MDT RNA, a total of 247 neurons in
®ve separate cultures were examined. Of these, 189 (77%) axons were stained in wholemounts by the MAP-1 anti-
body. This allowed us to observe axons independently ofhad abnormal distributions of endogenous NF-M. A total of
83 of these (44% of the abnormal cells) were completely their neuro®laments, since we have previously shown that
disruption of neuro®laments in Xenopus cultured neuronsunstained by RMO270 (Figs. 4C and 4D), whereas typically
all neurons of normal embryos are stained in 1-day-old cul- has no effect on microtubules (Lin and Szaro, 1995).
Over the range of doses used in the experiments describedtures (Lin and Szaro, 1994). The remaining 106 cells (56%
of the abnormal neurons) also had neurites devoid of neuro- below (1±2 ng of RNA), overall development of the spinal
cord, brain, and myotomes appeared grossly normal. At®lament staining, but these had large accumulations of neu-
ro®lament staining within their cell bodies (Figs. 4E and higher doses (4 ng) survival rates were lower (see Microin-
jection Procedures), and embryos began to show defects in4F). Nearly identical results were obtained in another set
of cultures (®ve from embryos injected with b-galactosidase neurulation, which included microcephaly, spina bi®da,
and twisted bodies. Thus, we made most of our observationsRNA and six from embryos injected with NF-MDT RNA)
stained by the anti-XNIF antibody, which recognizes a low- on embryos injected with the lower doses of RNA, which
were within the range typically reported by others for RNAmolecular-weight, a-internexin-like neuro®lament protein
that copolymerizes with NF-M (Charnas et al., 1992; Lin injections into Xenopus embryos (Hemmati-Brivanlou and
Melton, 1994; Smith and Harland, 1991). At these lowerand Szaro, 1994).
To understand these results, it is important to remember doses, the greatest effects were seen on cranial and motor
nerve development and on the emergence of ectopic neu-that the methanol ®xative used in these experiments fails
to ®x soluble proteins. (Because aldehyde ®xation destroys rons. These effects are described in more detail below.
Effects on cranial nerve development. Trigeminal nervesthe epitopes of our neuro®lament antibodies, we were un-
able to use other ®xatives.) Thus, we considered it more (cranial nerve V), which comprise three major nerve
branches (mandibular, Vmd ; ophthalmic, Vop; and maxillary,likely that the total lack of endogenous neuro®lament stain-
ing in some cells resulted from the washing out of unpoly- Vmx), are among the earliest cranial nerves to appear during
Xenopus embryonic development (Davies et al., 1982). Vmdmerized neuro®lament protein rather than from the sup-
pression of endogenous NF-M expression. ®rst appears at stage 22/23, and by stage 25/26 its axons
have reached their targets in the cement gland. Vmx emergesNot only did expression of NF-MDT disrupt neuro®l-
aments, it also affected desmin ®laments of cultured mus- slightly later and innervates an area dorsal and anterior to
the endings of the mandibular nerve. Vop begins to developcle cells. We suspected this was the case when we ®rst
saw the discrete cytoplasmic patches stained by the by stage 26 in a more horizontal plane, with targets overly-
ing the brain. By stage 28, all three branches are substan-XC10C6 antibody directed against exogenously expressed
NF-MDT (previously shown in Fig. 3B). Thus, we directly tially developed and have contacted their targets. The facial
(VII), glossopharyngeal (IX), and vagal (X) nerves developexamined desmin ®laments in cultured muscle cells with
an anti-desmin monoclonal antibody (Fig. 5). Like similar later, although the precise timing of their appearance has
yet to be documented in Xenopus. By stage 37/38, the VIIthcells containing NF-MDT protein stained with XC10C6,
muscle cells stained for desmin showed numerous small nerve is visible just anterior to the otic vesicle and has two
branches: the hyoid branch, which extends into the seconddiscrete patches of staining (Figs. 5C and 5D). Virtually
all muscle cells of embryos bilaterally injected with NF- branchial arch, and the palatine branch, which extends into
the upper jaw. The IXth nerve lies posterior to the oticMDT RNA showed similar desmin staining. By contrast,
the desmin staining of cultured muscle cells derived from vesicle and also has two branches, which extend to the
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FIG. 4. Disruption of endogenous neuro®lament organization in neurons expressing NF-MDT protein. (A, C, and E) Cultured neurons
(1 day) viewed with phase-contrast optics. (B, D, and F) The same cells as in A, C, and E, respectively, but stained by the antibody against
the tail domain of NF-M (RMO270), which recognizes only endogenously expressed full-length NF-M. (B) A neuron descended from a
blastomere injected with b-galactosidase mRNA showed normal neuro®lament staining (arrowhead points to the cell body). (D and F)
Neurons from embryos bilaterally injected with NF-MDTmRNA exhibited abnormal distributions of neuro®laments. In D, endogenous
neuro®lament staining was absent from both the soma and the neurite. In F, staining was absent from the neurite but heavily concentrated
within the soma. The scale bar applies to all panels.
second and third branchial arches. The Xth nerve is just uninjected side of tadpoles stained by the anti-MAP1 anti-
body. (Only the hyoid branch of nerve VII, the thirdposterior to IX and has three well-de®ned branches, a branch
extending anteriorly into the branchial arches (Xb), a second branchial arch branch of nerve IX, and the ophthalmic and
mandibular branches of nerve V are labeled, since the otherextending to the viscera (Xv), and a third, well-de®ned lat-
eral line branch (Xl). branches are in a different focal plane.) The left three panels
show the contralateral sides of these same tadpoles, whichThe right three panels of Fig. 6 show the normal develop-
ment of these cranial nerves at stage 28 (Fig. 6B) and stage were descended from blastomeres injected with NF-MDT
(Figs. 6A and 6C) or b-galactosidase RNAs (Fig. 6E).37/38 (Figs. 6D and 6F), as seen in wholemounts on the
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FIG. 5. Disruption of desmin organization in muscle cells expressing NF-MDT protein. The left three panels show phase-contrast views
of muscle cells in culture, and the right three panels depict these same cells, immuno¯uorescently stained by anti-desmin antibody. (A
and B) A muscle cell from an uninjected embryo, showing the normal distribution of desmin staining. (C and D) A muscle cell from an
embryo bilaterally injected with NF-MDT mRNA. The desmin network was disrupted and staining appeared in discrete patches. (E and
F) A muscle cell from an embryo injected with b-galactosidase mRNA. Desmin staining was similar to that of the normal muscle cell
(B). The scale is the same for all panels.
The degree to which various individual cranial nerves missing on the injected side). Vmd was the same length on
both sides, although the nerve on the injected side waswere inhibited varied among the embryos injected with NF-
MDT RNA, but these ®gures illustrate typical examples. slightly less intensely stained by anti-MAP1 than on the
control side. At stage 37/38, cranial nerves on the injectedOn the injected side of this particular stage 28 larval tadpole
(Fig. 6A), Vop was considerably shorter and had fewer sides of tadpoles expressing NF-MDT were even more se-
verely affected. In the example illustrated in Figs. 6C andbranches than that of the uninjected contralateral side (Fig.
6B, unlabeled arrowheads point to branches of Vop that were 6D, the injected side is shown in C and the uninjected side
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is in D. Vop on the injected side was thinner and shorter In this animal, the injected side (Fig. 7C) has fewer axons
emanating from the spinal cord (an example is shown atthan on the control side; Vmd, VII, and IX extended only to
the arrowhead labeled m) than on the contralateral controlthe dorsal regions of the branchial arches instead of to their
side (Fig. 7D). (As in A, the normal axons can also be seenrespective targets in the cement gland and ventral regions
out of focus through the animal in C). Of 57 experimentalof the branchial arches, which can be seen on the control
embryos scored, 39 showed asymmetric development ofside. Whereas all three branches of nerve X (Xb , Xv, and Xl )
their motor nerves. In contrast, both sides of all 43 b-galac-were clearly visible on the uninjected side, only a vaguely
tosidase-injected embryos exhibited symmetric and normalde®ned ganglion could be seen on the injected side (arrow-
motor nerve development, similar to that shown in Figs.head at X). Cranial nerves in tadpoles injected with b-galac-
7B and 7D.tosidase RNA were well developed and bilaterally symmet-
Ectopic neurons in tadpoles expressing NF-MDT. Onric. In the example of such a tadpole at stage 37/38 shown
one side of tadpoles unilaterally injected with NF-MDTin Figs. 6E and 6F, Vop, Vmd, VII, IX, and all three branches
RNA, we observed neurons outside of their usual locations.of nerve X developed symmetrically on both sides of the
These neurons were located just below the epidermis alongembryo. [The most ventral segment of Xv is present on the
the ¯ank of stage 37/38 tadpoles. These ectopic neuronsinjected side (Fig. 6E), but is slightly out of focus].
were absent from larval tadpoles examined between stagesOf 57 embryos that received a unilateral injection of NF-
22 and 28, but became very obvious after stage 35/36. Al-MDT RNA, 45 of them had markedly retarded cranial nerve
though we could see these cells with the MAP1 antibody,development on one side. Of 43 embryos similarly injected
we con®rmed they were neurons by staining them withwithb-galactosidase RNA, only 4 showed any asymmetries,
the RMO270 antibody directed against the tail domain ofwhich were slight.
endogenous NF-M. This was possible, since by stage 37/38Effects on motor nerve development. At early stages,
endogenous neuro®laments had begun to return. Figure 8Aunilaterally injected embryos appeared to respond poorly to
shows three such ectopic neurons in the ¯ank of a stagetactile stimulation on the injected side. Even at later stages,
37/38 tadpole. The equivalent region of the contralateralswimming was less vigorous in tadpoles injected with NF-
¯ank of the same embryo shows that these neurons wereMDT. Anatomically, development of motor nerves was
missing from the uninjected side (Fig. 8B). Of 19 tadpolesclearly affected by NF-MDT expression. Figure 7 shows mo-
injected with NF-MDT and scored at stage 37/38 withtor nerves in lateral views of wholemount embryos injected
RMO270, 14 had ectopic neurons on one side of the midline,with NF-MDT and stained by anti-MAP-1. In midlevel
with the number of ectopic cells averaging 5±6 and rangingmyotomes on the injected side of an embryo stained at stage
from 1 to more than 20. Of more than 50 control embryos28, motor axons were dramatically shortened (Fig. 7A) com-
examined, none had any such ectopic neurons on either sidepared to the contralateral uninjected side (Fig. 7B). (In Fig.
of the tadpole.7A, the normal axons can also be seen out of focus beneath
the affected axons, through the animal, as seen for example DISCUSSIONbelow the ``m'' at the arrowhead.) Effects on primary motor
nerves persisted through stage 37/38. Figures 7C and 7D In this study, RNA encoding a truncated form of Xenopus
NF-M was injected into embryonic blastomeres at the 2-show each side of the tail of an NF-MDT injected animal.
FIG. 6. Inhibition of cranial nerve development by NF-MDT. Embryos were injected unilaterally with either NF-MDT mRNA (A±D)
or b-galactosidase mRNA (E, F) at the 2-cell stage and then immunostained with the anti-MAP1 antibody as wholemounts at stage 28 (A
and B) or stage 37/38 (C±F). (A, C, and E) The side of the animal derived from the injected blastomere. (B, D, and F) The respective
contralateral uninjected side of the same animals. At stage 28, Vop (A, labeled arrowhead) developed to a lesser extent than on the
contralateral, uninjected side (B). The unlabeled arrowheads in B show additional segments of Vop that are missing from the injected side.
At stage 37/38 (C), cranial nerve development was more dramatically inhibited. (C) Inhibition of cranial nerves Vop, Vmd, VII, IX, and X.
(D) Normal development of these same nerves on the contralateral side. Xb, Xv , and Xl are especially well developed on this side compared
to the injected side. (E and F) Cranial nerve development was unaffected by expression of b-galactosidase. Cranial nerves on both sides
of the head developed symmetrically, and the extent of nerve development was similar to that in D. (The dorsal side of the animals shown
in E and F is rotated slightly forward.) Abbreviations: E, eye; O, otic vesicle; Vop , ophthalmic branch of the trigeminal nerve; Vmd,
mandibular branch of the trigeminal nerve; VII, branch of the facial nerve; IX, branch of the glossopharyngeal nerve; Xb , brachial branch
of the Xth cranial nerve; Xv visceral branch of Xth cranial nerve; Xl lateral line branch of the Xth cranial nerve. The scale bar applies to
all panels.
FIG. 7. Inhibition of primary motor nerve development by NF-MDT. Embryos were injected with NF-MDT mRNA into a single blasto-
mere at the 2-cell stage and later stained as wholemounts with the anti-MAP1 antibody. (A) Lateral view of mid-level myotomes on the
injected side of a stage 28 larval tadpole, showing inhibition of motor axon development. (B) The uninjected contralateral side of the same
animal at the same rostrocaudal level as in A, showing normal motor nerve development. (C) Lateral view of tail somites on the injected
side of a stage 37/38 tadpole. (D) The contralateral uninjected side of the same tadpole as in C. The injected side (C) had fewer motor
nerves emanating from the spinal cord than normal (D). Arrowheads at S point to the spinal cord. Arrowheads at m point to an example
of a motor nerve projecting to the somites. In these panels, rostral is to the right. (The negatives were reversed when printed to maintain
the same orientation in all panels.) The scale bars in B and D also apply to A and C, respectively.
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ments (Lin and Szaro, 1995). In that study, the neurites of
1-day-old neurons lacking neuro®laments were on average
only half as long as normal ones. In addition, between 40
and 50% of neurons containing the neuro®lament antibody
had neurites with abnormal morphologies. One of the chief
defects was a broadening of the neurites, presumably due
to the lack of structural reinforcement usually provided by
the neuro®laments. In the current study, we only visually
examined, without systematically measuring or tabulating,
the general effects that expression of NF-MDT had on neu-
ritic morphology among cultured neurons. In general, neu-
rites of neurons expressing NF-MDT were indeed shorter,
and some were morphologically abnormal. Examples of this
can be seen by comparing the neurite of a normal neuron
(Fig. 4A) to those of neurons expressing NF-MDT (Figs. 4C
and 4E). In these pictures, the neurites in neurons lacking
neuro®laments were clearly shorter than normally expected
in 1-day-old cultures, and they were also slightly broader.
In our previous study with injected whole IgGs, neuro®l-
ament immunoreactivity was con®ned entirely to the cell
body in nearly all of the cells, much like the subset of cells
expressing NF-MDT illustrated in Fig. 4F. These cells con-
stituted 43% of the neurons in cultures made from embryos
bilaterally injected with NF-MDT RNA. Another 34% of
the neurons in these cultures showed no endogenous stain-
ing for neuro®laments whatsoever (Fig. 4D). We think it is
unlikely that expression of NF-MDT suppressed the expres-
sion of endogenous protein. More likely, the methanol ®xa-
tive that was used for immunocytochemistry ®xed only
those ®laments that were at least partially polymerized.
Thus NF-MDT expression could disrupt the normal organi-
zation of neuro®laments, and in some cases, more severelyFIG. 8. The presence of ectopic neurons in the trunks of tadpoles
than antibodies.expressing NF-MDT. 2-cell stage embryos were injected unilater-
ally with NF-MDT mRNA and then stained as wholemounts at Unlike injected whole IgGs, which affected nearly all neu-
stage 37/38 with the anti-NF-M tail antibody (RMO270, 1:200). rons, NF-MDT failed to disrupt the ®laments of 23% of the
Several ectopic cells with neuronal morphologies appeared on the neurons examined. We considered that one possible source
injected side of the tadpole (arrowheads in A). These cells were of this difference might be due to our ability to monitor
absent from the uninjected side (B). The scale is the same for both the success of injections in antibody versus RNA injection
panels.
experiments. In the antibody-injection experiments, FITC±
dextran was coinjected to enable us to identify cells derived
from the injected blastomere, independently of phenotype.
In the RNA experiments, we found that coinjecting FITC±cell stage to disrupt intermediate ®laments in embryos dur-
dextran signi®cantly inhibited protein translation. More-ing the early stages of axonal development. We will ®rst
over, the staining of cultures for the b-galactosidase thatdiscuss the effects that expression of truncated NF-M had
was coinjected with NF-MDT destroyed the epitopes of ouron intermediate ®laments in culture and then proceed to a
neuro®lament antibodies. Therefore, to verify that embryos
consideration of effects on peripheral nerves and the appear-
used for culture were successfully bilaterally injected, we
ance of ectopic neurons.
stained embryos with X-gal after the neural tube was re-
moved and discarded any cultures from embryos not bilater-
ally labeled. The observation that all of the muscle cells inEffects on the Intermediate Filaments of Cultured
these cultures expressed NF-MDT protein and had dis-Cells
rupted desmin ®laments argues that neurons without dis-
rupted neuro®laments probably had at least some NF-MDT.One of the purposes of this study was to explore alterna-
tives to antibody disruption of intermediate ®laments. Pre- Thus, it seems more likely that the variation in effects seen
among neurons was caused either by variability in theviously we showed that injection of an anti-NF-M antibody
into 2-cell stage blastomeres speci®cally blocks neuro®la- amount of NF-MDT expressed or by differences among neu-
rons in the susceptibility of their ®laments to disruption.ments from entering the neurites of cultured neurons with-
out affecting the distributions of tubulin and micro®la- The amount of truncated mammalian NF-M suf®cient to
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disrupt ®laments in transfected ®broblasts is at least 1% of ther that neuro®laments of central nervous system axons
were among those more resistant to disruption or that thesethe level of endogenous ®lament proteins (Wong and Cleve-
land, 1990). To what extent the susceptibility of ®laments axons rely less on neuro®laments. For example, retinal gan-
glion cell axons have no detectable neuro®laments untilto disruption varies with composition is unknown. In the
case of antibody injections for example, neuro®laments of they reach the brain, during both development (Szaro et al.,
1989) and optic nerve regeneration (Zhao and Szaro, 1994).motor neurons are more susceptible than those of dorsal
root ganglion cells to an antibody against hyperphosphory- Conversely, developing peripheral axons of Xenopus are
®lled with neuro®laments up to their growth cones (Szaro etlated NF-H (Durham, 1992). Since Xenopus embryonic spi-
nal cord has at least nine different types of neurons (Roberts al., 1989). Peripheral axons may thus require the additional
mechanical strength provided by neuro®laments to assistand Clarke, 1982), neuro®laments could easily vary among
neurons both in composition and in number, making some them in traversing the large extracellular spaces they en-
counter outside of the central nervous system.cells relatively more resistant to NF-MDT than others.
Although neuro®laments help facilitate axonal develop-
ment, axons without neuro®laments may, if given enough
Effects on Neural Development of Intact Embryos time, eventually reach their targets. Xenopus embryos are
a developing system, and the shorter axons of experimentalUnlike the injected antibodies to NF-M, NF-MDT dis-
rupted desmin ®laments of muscle cells as well as neuro®l- neurons may be unrepresentative of their ®nal state. Cer-
tainly in the quiver mutant of the Japanese quail, at leastaments. Vimentin ®laments were probably affected too,
since equivalent constructs made for mammalian NF-M some axons reach their targets, because the birds hatch and
are viable. However, the birds have other abnormalities:disrupt them (Wong and Cleveland, 1990; Chin et al., 1991).
Thus in addition to providing another tool for examining they display tremors and have hypotrophied axons. The via-
bility of these birds may be due to the ability of their ner-the effects of neuro®lament disruption on axon develop-
ment, use of NF-MDT RNA enabled us to explore the ef- vous system to compensate for the lack of neuro®laments
and any subsequent defects this may cause in the timingfects of more generalized disruption of intermediate ®la-
ments on neural development. Although effects of cytokera- or number of axons reaching their targets. For example,
during peripheral nervous system development, neurons aretin, vimentin, and desmin disruption have been examined
previously in Xenopus embryos, those studies concentrated overproduced. Excess cells are eventually eliminated by
apoptosis, and the survival of the remaining neurons de-on effects outside of the nervous system (Torpey et al., 1992;
Klymkowsky et al., 1992; Cary and Klymkowsky, 1995; pends on contact with target cells. Thus, one possibility is
that in quiver mutants, any substantial reduction in theChristian et al., 1990). Comparing results obtained with
NF-MDT RNA to those obtained with neuro®lament anti- number of peripheral axons arriving at their targets would
later become obscured by the normally high rate of cellbodies should enable us begin to distinguish defects caused
by disruption of neuro®laments from those caused by dis- death. Other compensatory changes, such as increases in
the number of microtubules, may also play a role (Zhao etruption of other kinds of intermediate ®laments.
The effects we observed on cranial and primary motor al., 1994). These issues can be addressed better in mutant
and transgenic model systems, since in Xenopus, our meth-nerve development were virtually identical to those pre-
viously reported for antibody injections (Szaro et al., 1991; ods only temporarily disrupt neuro®laments.
Ectopic neurons appeared along the ¯ank of tadpoles ex-Lin and Szaro, 1995). Although some initial axonal out-
growth appeared to occur, later cranial and motor nerve pressing NF-MDT but not in antibody-injected ones. These
neurons were found just beneath the epidermis. We believedevelopment was signi®cantly stunted. In our previous an-
tibody injection studies, similar observations led us to con- this effect was caused by the disruption of intermediate
®laments other than the neuro®laments, since it did notclude that the principal role of neuro®laments in these ax-
ons was to help provide suf®cient mechanical strength to happen with injection of neuro®lament antibodies. A num-
ber of possibilities exist for the origins of these cells. Inter-support the elongation of growing axons. Those papers gave
a fuller treatment of these ideas than we intend to give here, mediate ®laments have been suggested as important cyto-
plasmic factors in¯uencing gene expression (Traub andbut we wish to make a few additional observations and
comments. Shoeman, 1994). Indeed, the appearance and location of our
ectopic neurons resembles those obtained by overex-In our current experiments, development of the central
nervous system was much less affected than of the periph- pression of the transcription factor NeuroD (Lee et al.,
1995); thus, there may be some connection. Another possi-eral nervous system. Optic nerve development appeared
normal on both sides of the animal, and the major ascending bility is that disruption of intermediate ®laments may affect
neural crest cell migration. Ectopic neurons appeared onlyand descending tracts appeared to be stained equivalently
on both sides of the animal. One possible reason for this after neural crest cells are known to migrate, which in Xeno-
pus development begins along various pathways betweenmay be the dif®culty of observing subtle effects among the
complex axonal pathways of the central nervous system. stages 28 and 32 (Krotoski et al., 1988). Conceivably, disrup-
tion of intermediate ®laments could have changed the dis-Many axons decussate, and the ventral retina and forebrain
of Xenopus originate from cells on both sides of the midline tribution of important guidance cues anchored in the mem-
branes of cells lying along neural crest cell migration path-(Jacobson and Hirose, 1978). Two other possibilities are ei-
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during the differentiation of the dorsal myotome in Xenopusways. For example, somites lie along these routes, and
laevis. Differentiation 56, 31±38.recent studies in zebra®sh have shown that somites express
Cary, R. B., and Klymkowsky, M. W. (1995). Disruption of interme-cues important for guiding neural crest cells into their cor-
diate ®lament organization leads to structural defects at the in-rect pathways (Jesuthasan, 1996). Disruption of desmin and
tersomite junction in Xenopus myotomal muscle. Developmentvimentin ®laments alters the membranes of myotomal cells
121, 1041±1052.
at the intersomite junction (Cary and Klymkowsky, 1995), Charnas, L. R., Szaro, B. G., and Gainer, H. (1992). Identi®cation
and thus similar changes could alter cues that normally and developmental expression of a novel low molecular weight
guide these neurons, resulting in their displacement. Dis- neuronal intermediate ®lament protein in Xenopus laevis. J.Neu-
ruption of guidance cues in peripheral targets may have also rosci. 12, 3010±3024.
played some role in axonal development of the tail, since Chin, S. S. M., Macioce, P., and Liem, R. K. H. (1991). Effects of
truncated neuro®lament proteins on the endogenous intermedi-in the antibody injection studies those axons were largely
ate ®laments in transfected ®broblasts. J. Cell Sci. 99, 335±350.unaffected (Szaro et al., 1991). In tadpoles expressing NF-
Christian, J. L., Edelstein, N. G., and Moon, R. T. (1990). Overex-MDT, signi®cantly fewer axons were seen emanating from
pression of wild-type and dominant negative mutant vimentinthe spinal cord, although the lengths of those axons which
subunits in developing Xenopus embryos. New Biol. 2, 700±711.did emerge seemed less compromised than those more ante-
Colucci-Guyon, E., Portier, M.-M., Dunia, I., Paulin, D., Pournin,rior (Figs. 7C and 7D).
S., and Babinet, C. (1994). Mice lacking vimentin develop and
In conclusion, expression of a truncated neuro®lament reproduce without an obvious phenotype. Cell 79, 679±694.
protein in Xenopus embryos led to a generalized disruption Davies, S. N., Kitson, D. L., and Roberts, A. (1982). The develop-
of intermediate ®laments. These embryos exhibited a vari- ment of the peripheral trigeminal innervation in Xenopus em-
ety of defects in their developing nervous systems. Some of bryos. J.Embryol.Exp.Morphol. 70, 215±224.
these effects, such as reductions in the extent of peripheral Davis, L. G., Kuehl, W. M., and Battey, J. F. (1994). ``Basic Methods
in Molecular Biology.'' Appleton and Lange, Norwalk.nerve development, were identical to those obtained in pre-
Dent, J. A., Polson, A. G., and Klymkowsky, M. W. (1989). A whole-vious experiments that used injected neuro®lament anti-
mount immunocytochemical analysis of the expression of thebodies. Others, chie¯y the emergence of ectopic neurons
intermediate ®lament protein vimentin in Xenopus. Develop-along the ¯ank, were new and thus likely to have resulted
ment 105, 61 ±74.from the disruption of other intermediate ®laments. Clearly
Durham, H. D. (1992). An antibody against hyperphosphorylatedadditional experiments are needed to ®nd the source of
neuro®lament proteins collapses the neuro®lament network in
these latter effects. Injections of antibodies speci®cally tar- motor neurons but not in dorsal root ganglion cells. J. Neuropa-
geting desmin, vimentin, or cytokeratins could be used to thol. Exp. Neurol. 51, 287 ±297.
determine which ®laments were responsible. Similarly, in- Fliegner, K. H., Kaplan, M. P., Wood, T. L., Pintar, J. E., and Liem,
terchanging neural tubes, neural crests, somites and ¯ank R. K. H. (1994). Expression of the gene for the neuronal intermedi-
ectoderm between normal and altered embryos would en- ate ®lament protein alpha-internexin coincides with the onset
able us to determine which tissues were responsible. The of neuronal differentiation in the developing rat nervous system.
J.Comp.Neurol. 342, 161 ±173.history of embryonic transplantations in Xenopus embryos
Fuchs, E. (1994). Intermediate ®laments and disease: Mutationstells us that such experiments are feasible.
that cripple cell strength. J.Cell Biol. 125, 511±516.
Fuchs, E., and Weber, K. (1994). Intermediate ®laments: Structure,
dynamics, function and disease. Annu.Rev.Biochem. 63, 345±
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